COMMUNIQUÉS West-GlobeNewswire

Cardiff Oncology to Report Second Quarter 2024 Results and Provide Business Update
01/08/2024
- Management will hold a conference call on Thursday, August 8 at 4:30 p.m. ET/1:30 p.m. PT - SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company [...]
OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024
01/08/2024
MIAMI, Aug. 01, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2024 after the close of the U.S. financial markets on [...]
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
01/08/2024
FOSTER CITY, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]
Zymeworks Provides Corporate Update and Reports Second Quarter 2024 Financial Results
01/08/2024
Reported $395.9 million in cash resources as of June 30, 2024, which when combined with certain anticipated regulatory milestone payments provides projected cash runway into 2H 2027 Priority Review of the Biologics [...]
NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results
01/08/2024
LNCB74 (B7-H4 ADC) GLP tox studies completed and targeting an IND application by year-end NC410 combo with pembrolizumab ovarian cohort enrollment completed Cash of approximately $86.4 million expected to fund [...]
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2024
01/08/2024
Generated Product Sales of $21 Million in the Second Quarter, and $45 Million in the Six Months Ended June 30, 2024 Received $113 Million Procurement Order from U.S. Government for Oral TPOXX in July Corporate Update [...]
Sight Sciences Reports Second Quarter 2024 Financial Results and Narrows Full Year 2024 Financial Guidance
01/08/2024
MENLO PARK, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, [...]
Elutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross Proceeds
01/08/2024
SILVER SPRING, Md., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today announced that it had received gross proceeds of [...]
Sensus Healthcare Issues Reminder That its Second Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, August 8, 2024
01/08/2024
BOCA RATON, Fla. , Aug. 01, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological [...]
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
01/08/2024
VALENCIA, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin [...]
Shattuck Labs Reports Second Quarter 2024 Financial Results and Recent Business Highlights
01/08/2024
– Announced updated positive interim data from the Phase 1B dose-expansion clinical trial of SL-172154 in combination with Azacitidine (AZA) in frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant ( [...]
TOMI Environmental Solutions, Inc. Reports 170% Sequential Growth in Second Quarter Revenue With Break Even EPS
01/08/2024
Company Reports Operating Income of $122,000 And Positive Net Income - Performance Driven By Growth in International, Mobile Equipment and BIT Solutions Sales - FREDERICK, Md., Aug. 01, 2024 (GLOBE NEWSWIRE) -- TOMI [...]
Lipella Pharmaceuticals Announces Closing of $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules
01/08/2024
PITTSBURGH, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”) (Nasdaq: LIPO), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, [...]
Vision Sensing Acquisition Corp. Announces Intention to Extend the Period to Consummate Its Initial Business Combination to September 3, 2024
31/07/2024
NEW YORK, July 31, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “ Company ”) a special purpose acquisition company, announced today that it has notified Continental Stock [...]
STERIS Raises Dividend to $0.57 per share
31/07/2024
DUBLIN, IRELAND, July 31, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. This represents a $ [...]
NADP Celebrates Passage of Key Dental Benefit Legislation Enhancing Transparency and Consumer Choice
31/07/2024
DALLAS, July 31, 2024 (GLOBE NEWSWIRE) -- The National Association of Dental Plans (NADP) is pleased to announce the successful passage of several important state bills that align with the association’s mission to [...]
CVRx to Present at the Canaccord Genuity 44th Annual Growth Conference
31/07/2024
MINNEAPOLIS, July 31, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the Canaccord Genuity 44 th Annual [...]
Ocugen, Inc. Announces Proposed Public Offering of Common Stock
31/07/2024
MALVERN, Pa., July 31, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Nasdaq: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced [...]
Beyond Air® Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia
31/07/2024
GARDEN CITY, N.Y., July 31, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]

Pages